Smulyan H, Safar M E
State University of New York Health Science Center, Syracuse 13210, USA.
Ann Intern Med. 2000 Feb 1;132(3):233-7. doi: 10.7326/0003-4819-132-3-200002010-00010.
Because antihypertensive therapy is effective in elderly patients with isolated systolic hypertension, attention has been focused on the systolic blood pressure as a predictor of cardiovascular risk. However, it is a normal diastolic pressure that separates patients with isolated systolic hypertension from those with essential hypertension. The normal diastolic and elevated systolic pressures are largely due to age-related stiffening of the aorta. An indistensible aorta causes the pressure pulse to travel faster than normal, where it is quickly reflected off the peripheral resistance. The reflected wave then returns to the central aorta in systole rather than diastole. This augments the systolic pressure further, increasing cardiac work while reducing the diastolic pressure, on which coronary flow is dependent. The potential harm of further reducing the diastolic pressure with antihypertensive therapy, especially in patients with coronary heart disease, underlies the controversial "J curve." By decreasing the blood pressure, all antihypertensive agents improve aortic distensibility, but no agents do so directly; the nitrates come the closest. Such an agent would be useful because any therapeutic increase in aortic distensibility would decrease systolic pressure without greatly reducing diastolic pressure. The problem is complicated by the suspected inaccuracy of the cuff technique in predicting the aortic diastolic pressure. New noninvasive methods to predict the aortic diastolic pressure may help in the future. At present, the combination of a high systolic and normal diastolic pressure-a widened pulse pressure-seems to be the best predictor of cardiovascular risk in patients with hypertension or heart disease. Patients with isolated systolic hypertension should be treated, but marked diastolic hypotension should be avoided.
由于降压治疗对老年单纯收缩期高血压患者有效,收缩压作为心血管风险的预测指标已受到关注。然而,正是正常的舒张压将单纯收缩期高血压患者与原发性高血压患者区分开来。正常的舒张压和升高的收缩压很大程度上归因于与年龄相关的主动脉硬化。僵硬的主动脉使压力脉冲的传播速度比正常情况快,在那里它很快从外周阻力反射回来。反射波然后在收缩期而非舒张期返回主动脉中部。这进一步增加了收缩压,增加了心脏负荷,同时降低了舒张压,而冠状动脉血流依赖于舒张压。用降压治疗进一步降低舒张压的潜在危害,尤其是在冠心病患者中,构成了有争议的“J曲线”的基础。通过降低血压,所有降压药物都能改善主动脉的可扩张性,但没有一种药物能直接做到这一点;硝酸盐类药物最接近。这样一种药物将是有用的,因为主动脉可扩张性的任何治疗性增加都会降低收缩压而不会大幅降低舒张压。袖带技术在预测主动脉舒张压方面可能存在的不准确问题使情况变得复杂。未来,预测主动脉舒张压的新的非侵入性方法可能会有所帮助。目前,收缩压高和舒张压正常——脉压增宽——的组合似乎是高血压或心脏病患者心血管风险的最佳预测指标。单纯收缩期高血压患者应该接受治疗,但应避免明显的舒张压过低。